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Abstract
Retinoblastoma (RB) is the most common intraocular tumor in children. It arises 
from the nuclear layer of the retina, with different growth patterns: endophytic, 
exophytic, and mixed. Retinoblastoma also has characteristic histopathological 
appearance with areas of viable tumor, necrosis, and calcifications. The tumor dif-
ferentiation can be determined by the presence of rosettes—Flexner-Wintersteiner 
rosettes as well as fleurettes—and tends to become less differentiated with age. 
Histopathological risk factors are used as prognostic indicators and will be dis-
cussed in this chapter together with the typical tissue diagnostic features. These 
will include optic nerve/choroidal invasion, extraocular extension, and anterior 
segment involvement. Other prognostic factors with less impact will be discussed 
as well including the amount of necrosis, mitotic figures, and grading of anaplasia. 
Furthermore, we will briefly discuss different regression patterns and posttreat-
ment findings in enucleated globes.
Keywords: retinoblastoma, pathological prognostic indicators, optic nerve invasion, 
choroidal invasion, pathological classification
1. Introduction
Retinoblastoma was first ever described by Petras Pawius from Amsterdam in 
1597, and it wasn’t until 1809 when James Wardrop of Edinburgh established its 
origination from the retina and recommended enucleation as a primary treatment 
method for saving lives [1–3]. Nine years later, the first case of fungus hematodes, 
old name of retinoblastoma, was reported in the American literature [2, 4]. In the 
following three decades when the microscope was introduced, Virchow, the well-
known pathologist, claimed that this tumor is a glioma as it arises from glial cells  
[2, 5]. Nevertheless, both the pathologist Simon Flexner (1891) and ophthalmolo-
gist Hugo Wintersteiner (1897) believed independently that this tumor is actually a 
neuroepithelioma due to the presence of cellular rosettes harboring a central lumen 
histologically. In fact, the Flexner-Wintersteiner rosettes that are diagnostic for 
retinoblastoma are named after these two physicians [2, 6, 7]. Later in the nine-
teenth century, the American pathologist Verhoeff confirmed that undifferentiated 
retinal cells are the original nidus of this tumor; thus, he called it retinoblastoma. 
This term was first adopted by the American Ophthalmology Society in 1926, and it 
has been in use since then [2, 8].
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2. Gross pathology
The first step of grossing an enucleated eye in preparation for histopathological 
microscopic examination is establishing the laterality. Several anatomical landmarks 
provide useful cues to orient the globe properly, and these include the cornea, 
oblique muscles, and ciliary arteries. The corneal horizontal diameter is larger than 
its vertical diameter by around 1 mm, and this produces an oval shape (Figure 1A). 
The insertion of the superior oblique muscle tendon after originating from the 
trochlea is in the superior outer (temporal) quadrant just behind the insertion of 
the superior rectus muscle tendon. The inferior outer (temporal) quadrant receives 
the insertion of inferior oblique muscle, just lateral to the optic nerve (Figure 1B). 
Locating the horizontal planes can be done affirmatively by identifying the long 
posterior ciliary arteries that run horizontally at 3 and 9 o’clock [9].
In the past, the enucleated eye was grossed and processed to produce one pupil-
optic nerve (PO) section, which is then studied histopathologically. This practice 
was abandoned following the consensus of the International Retinoblastoma 
Staging Working Group (IRSWG) in 2009 where the efforts of 85 members from 
Figure 1. 
Grossing an enucleated eye with retinoblastoma: (A) vertical corneal measurements; (B) inferior oblique 
muscle insertion located temporal (lateral) to the optic nerve (asterisk); (C, D) pupil-optic nerve (PO) 
section; (E) cassettes containing both calottes cut in bread-loaf pattern (red arrows), while the PO section is 
submitted in a separate cassette.
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24 different countries were joined to establish guidelines for tissue processing and 
handlining as well as staging. They concluded that the entire enucleated globe 
should be examined microscopically. This can be achieved by dividing the eye into 
four blocks. The optic nerve, tumor, and anterior chamber structures are included 
in the central pupil-optic nerve (PO) section composing one block as demonstrated 
in (Figure 1C, D). Two mirrored blocks composed of the calottes, representing the 
remaining eye tissue after harvesting the PO section, are usually cut consecutively 
in a bread-loaf fashion and embedded on edge to increase the examined surface 
area of the choroid, and this will subsequently improve the chances of detection 
of choroidal involvement (Figure 1E). The last block comprises the optic nerve 
margin cross section, and this is usually taken initially before cutting the eye. 
The optic nerve head, lamina cribrosa, and optic nerve posterior to the lamina 
cribrosa in a single section plane are usually displayed in the PO section as shown 
in (Figure 1D) [9].
Enucleation of the eye not only enables histopathological diagnosis, but it also 
yields fresh ocular tissue on which molecular and genetic testing can be carried 
out. Such tests are of paramount importance as their results are needed for family 
counseling and prognosis prediction. To facilitate this, guidelines and protocols 
were proposed to ensure preservation of the harvested ocular tissue for examination 
to obtain the best histopathological and molecular testing results. This guideline 
states that the enucleated globe should be processed and opened soon after surgery 
in order to prevent proteins and nucleic acid denaturation. Then, the optic nerve 
length is measured and documented in mm, and this is followed by preparing the 
block of the optic nerve margin cut section before proceeding with opening the eye. 
The next step involves opening the globe with the aid of transillumination, which is 
helpful in localizing the margins of the intraocular mass in addition to planning the 
collection of the PO section. Opening the eye can be accomplished using one of two 
techniques. The first proposed technique involves creating a window opening in the 
sclera adjacent to the edge of the bulk of the tumor. This scleral window is ideally 
created using a trephine. The second method is done utilizing a large bore 22-gauge 
needle that is used under sterile conditions to aspirate fresh tumor cells/tissue. The 
needle is inserted obliquely under direct visualization via the sclera into the poste-
rior chamber behind the lens, and aspiration takes place once it is inside the tumor 
mass. Finally, the globe is fixed in an adequate amount of formalin for a minimum 
of 48 hours [10].
Figure 2. 
(A) Gross photo showing the encephaloid appearance of the tumor. (B) White flecks representing the 
calcification.
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Macroscopically, the tumor has an encephaloid appearance, and this is not 
surprising given that it arises from the retina which resembles the neurological 
tissue (Figure 2A). The tumor is typically white in color, and it encompasses lightly 
colored flecks. In fact, these flecks are analogous to the dystrophic calcification 
within the necrotic tissue microscopically (Figure 2A) [10].
3. Histopathology
3.1 Tumor origin
Embryologically, retinoblastoma tumors initiate from the inner layer of the optic 
cup that is derived from the neuroectoderm which is a neurological tissue. At the 
cellular level, the retinoblastoma constituent cells appear as small, roundish blue 
cells. Retinal differentiation in RB is categorized as the following: differentiated, 
undifferentiated, or necrotic. Differentiated tumors are furtherly subdivided into 
(1) “fleurettes” exhibiting advanced photoreceptor differentiation, (2) the classic 
Flexner-Wintersteiner rosettes representing early retinal differentiation, (3) Homer 
Wright rosettes with primitive neuroblastic differentiation, or (4) poorly differenti-
ated [11]. These rosettes in an ascending order of differentiation include Homer 
Wright, Flexner-Wintersteiner rosettes, and fleurettes providing examples of these 
histologic structures (Figure 3) [2, 10, 12–14]. The Flexner-Wintersteiner rosettes 
when examined by high magnification microscopy demonstrate a ring of nuclei sur-
rounding a central clear lumen corresponding to the subretinal space (Figure 3A). In 
comparison, the Homer Wright rosettes surround a central tangle of neural filaments 
with no clear distinct lumen (Figure 3A) [10, 11]. The different types of rosettes and/
or fleurettes (Figure 3B) observed in RB tumors represent varying degrees of differ-
entiation, and these are recognized based on the histologic architectural pattern.
3.2 General histopathology
On microscopic examination, the neuroblastic tumor cells are mitotically active 
with scanty cytoplasm and irregular basophilic nuclei. Apoptosis leading to necrosis 
Figure 3. 
(A) Different types of rosettes noted by low power. High-power slide showing two types of rosettes: Flexner-
Wintersteiner rosettes (arrow) and Homer Wright rosettes (asterisk). (B) Bland-looking pinkish tumor cells 
with fleurettes (arrow) (original magnification ×1000 stained with hematoxylin and eosin).
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is also frequently seen in these tumors. Necrotic areas may develop dystrophic calci-
fication which is the source of the red purple color seen on sections stained with the 
hematoxylin and eosin (H&E) stain (Figure 4) [2, 10, 15]. These calcifications are 
of great clinical value, and they are usually detected by B-scan ultrasonography.
The level of differentiation of these cells varies, and there is a negative correlation 
between advancing age and the level of differentiation (less differentiation in older 
children). Notably, an inverse relationship was detected between retinal differentia-
tion and age, where older infants present with poorer retinal differentiation than 
young infants in whom microscopic examination of their enucleated eyes revealed 
good differentiation with the presence of Flexner-Wintersteiner rosettes [11, 16].
Histopathological examination of removed tumors showed that one-fifth of the 
cases have foci of differentiated photoreceptors. This condition is attributed to a lesser 
degree of apoptosis and cellular turnover in highly differentiated tumors as photorecep-
tor differentiation, which persist regardless of the age, unlike Flexner-Wintersteiner 
rosettes, which were noted to decrease with older age [10, 11]. It was hypothesized that 
retinoblastomas originate from retinomas or retinocytomas, which are benign tumors 
entirely formed of differentiated photoreceptors and what proves this theory is the 
presence of well-differentiated photoreceptor foci at the base of endophytic retinoblas-
tomas. Moreover, Dimaras demonstrated the presence of both RB1 gene mutation in 
these benignly behaving precursor tumors mentioned above [10, 17].
3.3 High-risk histopathological features
Detecting the presence of high-risk features on histopathological examination 
is of utmost significance. This is because of the implications these factors have 
on the risk of systemic metastasis and overall survival. Moreover, the presence of 
these factors dictates the institution of post-enucleation systemic chemotherapy to 
improve survival rates and limit the risk of metastasis [9, 11, 18–22].
Several studies from different parts of the world attempted to identify and 
evaluate these high-risk factors that include the following: retrolaminar optic 
nerve invasion (Figure 5), massive choroidal invasion (Figures 6 and 7), ante-
rior segment tumor invasion, and extraocular/extra-scleral tumor extension 
(Figure 8) [9, 11, 18–20, 23].
Optic nerve invasion is usually classified as prelaminar (anterior the lamina 
cribrosa), laminar (involving the lamina cribrosa but not extending beyond it), 
retrolaminar (extending beyond the lamina cribrosa), and tumor at the surgical cut 
margin (Figure 5A–C). In addition to the length of invasion, the focus of tumor 
Figure 4. 
Low-power histopathological appearance of the tumor demonstrating pseudorosettes. Note the extensive 
necrosis (N) and calcification (arrow) (original magnification ×40 hematoxylin and eosin).
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Figure 6. 
(A) Microscopic photos showing focal choroidal invasion <3 mm, (hematoxylin and eosin ×100). (B) Massive 
choroidal invasion>3 mm, (hematoxylin and eosin ×12.5). Note the postlaminar optic nerve invasion (arrow).
invasion must be determined by measuring the maximum depth of invasion into 
the optic nerve. This is achieved by measuring from the internal limiting membrane 
(ILM) of the optic disc or Bruch’s membrane if ILM was destroyed by the tumor to 
the deepest area of invasion as demonstrated in (Figure 5C) [24, 25]. On the other 
hand, experts defined massive as more than 3 mm foci of choroidal invasion whether 
in thickness or width, whereas focal choroidal invasion was defined as less than 
3 mm foci of choroidal invasion whether in thickness or width (Figures 6 and 7). 
Another helpful anatomical definition is whether the tumor cells are reaching the 
inner scleral layers in massive invasion or not reaching the sclera in focal invasion [9, 
11, 18, 19, 26]. It is important not to misinterpret artificial tumor seeding of the cho-
roid or other ocular structures as invasion. This will prevent over-reporting of high-
risk features (such as choroidal invasion) and will consequently avoid additional 
Figure 5. 
Histopathological photos of several retinoblastoma tumors showing various degrees of optic nerve invasion: 
(A) prelaminar, (B) intralaminar, and (C) postlaminar, measuring the depth from Bruch’s membrane 
(hematoxylin and eosin ×40).
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unnecessary treatments in these vulnerable children. Artificial seeding classically 
consists of tumor cells clustered in small groups along with many necrotic cells in 
natural or potential ocular spaces (e.g., suprachoroidal space, anterior chamber, or 
subarachnoid space of the optic nerve), sectioning artifacts created during tissue 
preparation and/or ocular surfaces (e.g., episclera, optic nerve meningeal sheath). 
On the other hand, truly existent invasion consists of solid nests of infiltrative tumor 
cells that anatomically destroy and substitute the area of invasion; however, necrosis 
is rarely seen except if the tumor is massive [9, 10].
In the literature, there are several key studies that looked at these high-risk 
factors. A large study conducted by Eagle et al. from the USA looked at the over-
all occurrence of high-risk features in children with unilateral retinoblastoma 
(n = 387), whether treated preoperatively or not, and found an incidence of 
20.4%. Further evaluation of the untreated group (n = 297) revealed that high-risk 
features were present in 18.5% of the enucleated eyes. Among these, retrolaminar 
optic nerve invasion was the commonest feature occurring in 10.4% followed by 
massive choroidal invasion in 8.1%, and lastly a combination of both features was 
observed in 3.4% [11]. In fact, these percentages were similar to those (11.6 and 
9.3% for retrolaminar optic nerve invasion and massive uveal invasion, respec-
tively) reported previously by large specialized American treatment centers [11, 
27]. The incidence of high-risk features is to the lower side in developed countries 
(e.g., 20% in the USA); yet, higher rates were observed in developing countries 
Figure 7. 
(A) Massive choroidal invasion noted grossly (G). (B) Corresponding histopathology massive choroidal 
invasion (H). Note the postlaminar optic nerve invasion (arrow) (hematoxylin and eosin, scanned slide).
Figure 8. 
Extraocular extension identified during surgery (A), grossing (B), and by microscopy (C). Note tumor cells on 
the outer surface of the sclera (EOE, hematoxylin and eosin ×40).
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ranging between 29 and 48% [28, 29]. Gupta studied retrospectively 142 cases of 
retinoblastoma eye enucleated over a 5-year period and found that the high-risk 
histopathologic features were present in 54.2% of these eyes. Choroidal invasion 
was the most frequent where it was detected in 40% followed by retrolaminar optic 
nerve invasion 17% and less commonly other ocular structures such as the iris and 
sclera. This study further linked the identified high-risk features to the clinical 
presentation and reported a positive correlation between age > 24 months and 
choroidal invasion, whereas iris neovascularization correlated with both retrola-
minar optic nerve invasion and choroidal invasion [11, 18]. Furthermore, Kaliki 
evaluated patients with an International Classification of Retinoblastoma (ICRB) 
classes D and E for high-risk features and reported their presence in 17% of class 
D eyes (15/87) and 24% of class E eyes (102/432). The fact that high-risk features 
were more likely to be present in advanced disease is evidently supported by the 
fact that 10% of patients demonstrating high-risk features on histopathology in the 
previous study developed metastasis which was fatal in two children. To compare, 
none of the children in group D with high-risk features developed metastasis nor 
died [19].
Overall, choroidal and optic nerve invasion reported incidences in the litera-
ture are variable and were noticed to be higher in previous publication than more 
recent ones [23, 28, 30–34]. To add, a trend of higher occurrence was observed 
in developing countries and specific geographic locations such as Asia and India, 
and this is explained by the later presentation and unique biological behavior 
of tumors in these areas. This variability in incidence was looked at by Eagle 
where he attributed it to multiple factors including diagnosis to enucleation time, 
reporting institute location and ununified assessing techniques of enucleating 
specimens [11].
The survival rates in the presence of these high-risk features are usually 
decreased. In general, patients with massive choroidal invasion had a 70% survival 
rate, while patients with tumor extending up to the optic nerve cut margin had an 
obviously lower survival rate of approximately 35%. On the contrary, those with 
prelaminar optic nerve invasion had excellent survival rates reaching more than 
90% [2, 24, 35].
3.4 Other histopathological features
3.4.1 Necrosis
Another characteristic feature seen in RB cases is tumor or ocular tissue necrosis. 
This condition occurs secondary to mitotically active tumor cells that grow 90–110 
micron from the tumor-feeding vessels resulting in ischemia and necrosis. Papillary 
appearance may be seen in necrotic tissue termed as pseudorosettes (wrong nomen-
clature) consisting of basophilic viable tissue resembling sleeves and cuffs measur-
ing 100um from the central blood vessels separated by eosinophilic necrotic sheets 
(Figure 9) [10, 15, 20].
Chong studied the association between extensive tumor and ocular tissue necro-
sis in RB enucleated eyes with high-risk histopathological features. Extensive tissue 
necrosis was defined as more than 95% of ocular tissue or tumor to be necrotic 
in enucleated samples. The total number of eyes showing extensive necrosis is 11 
(25.6%) out of 43 enucleated eyes. Histopathological high-risk features were more 
prevalent and statistically significant in enucleated eyes with extensive necrosis. 
On review of histopathological slides, 11 (100%) had optic nerve invasion with 8 
(72.2%) showing retrolaminar invasion and 9 (81.8%) with choroidal invasion. This 
study concluded that the presence of extensive necrosis of tumor or ocular tissue in 
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RB should alert the ocular pathologist to extensively review the slides for high-risk 
histopathological features to improve the survival rate and lower the risk of metas-
tasis [20].
3.4.2 Growth pattern
RB originates and destroys the neurosensory retina. The tumor is subdivided 
into two types based on the growth pattern. Endophytic tumors, which are 
known to be the most common type, arise from the inner layers of the retina 
which maintains its attachment and normally invades into the vitreous chamber 
(Figure 10C, D) [10]. They are clinically visible by ophthalmoscopy as white 
mass lesions surrounded by fine feeding vessels, which may be mistaken for an 
astrocytic hamartoma [36]. These tumors may also occasionally seed the anterior 
chamber. On the other hand, exophytic tumors arise from the outer retinal layers 
in between the sensory retina and the retinal pigment epithelium and grow 
outward typically causing high bullous retinal detachments which may progress 
to total retinal detachment (Figure 10A, B) [10, 36]. They are usually invisible 
by ophthalmoscopy but may initially be identified with difficulty as small gray 
masses [36]. They may also cause anterior displacement of the lens-iris diaphragm 
and secondary angle closure [10]. When presenting with a total retinal detach-
ment, exophytic tumors may be mistaken as Coats disease, persistent hyperplastic 
primary vitreous, retinopathy of prematurity, or retinal dysplasia [36]. The 
two previously mentioned growth patterns may overlap manifesting as a mixed 
endophytic-exophytic retinoblastoma [10]. Rarely, a diffuse infiltrating RB may 
be found which grows diffusely within the retina without forming a discrete mass. 
These usually present with signs suggestive of inflammation and are misdiagnosed 
as uveitis [36].
In 1990, Palazzi classified 297 cases of RB into two types of growth pattern. 
Their study showed that 61% of the cases were endophytic, while 39% of the cases 
were exophytic [37]. Similarly, in a more recent study published in 2014, Nawaiseh 
reported 42 cases of RB where 45% of cases were endophytic, 33% were exophytic, 
and 21% were mixed endophytic-exophytic. The study did not report any cases of 
the diffuse infiltrating type [36]. However, Taktikos reported the diffuse infiltrat-
ing type in 1% of the cases in his published article in 1966 [38].
The growth patterns have different impacts on the pathological features of 
the tumor in the eyes with retinoblastoma and no treatment prior to enucleation. 
Endophytic tumors, which have a direct contact with the vitreous, are more likely 
Figure 9. 
Pseudorosettes with viable blue cell tumor survived for about 100 um from the central blood vessels, surrounded 
by pink necrotic tissue.
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to be associated with vitreous seeds than exophytic tumors. On the other hand, 
exophytic tumors characteristically grow toward the choroid with a higher risk of 
choroidal invasion than endophytic tumors. This theory was supported by Palazzi’s 
findings where 71% of tumors with choroidal invasion had an exophytic growth 
pattern [37]. Nawaiseh also found that all cases with massive choroidal invasion 
occurred with tumors of exophytic growth patterns [36].
3.5  Correlation between clinical classifications and the high-risk pathological 
features
Wilson and Kaliki found that group Vb eyes according to the Reese-Ellsworth 
(RE) classification (eyes with vitreous seeds) have higher incidence of high-risk 
features than group Va (eyes without vitreous seeds) [19, 39, 40]. The risk of optic 
nerve invasion (laminar or postlaminar) was found to be 58% in that group, while 
the risk of massive choroid invasion was as low as 29% [39]. Nawaiseh correlated 
the above conclusions by Wilson to his own findings and anticipated that endo-
phytic tumors are more likely to be associated with optic nerve invasion rather than 
choroidal invasion based on the fact that vitreous seeding was more likely to be 
associated with an endophytic growth pattern [36].
A mixed tumor growth pattern indicated a more advanced tumor stage and a 
more damaging tumor. Nawaiseh found that the mixed tumor growth pattern was 
more likely to be associated with neovascular glaucoma and with more advanced 
IIRC groups (67% were associated with IIRC group E, the most advanced stage of 
Figure 10. 
(A) Gross photo of an exophytic growth pattern (posterior to the retina). (B) Low magnification sample 
demonstrating exophytic growth pattern (hematoxylin and eosin). (C) Gross photo of an endophytic growth 
pattern (anterior to the retina) with subretinal fluid. (D) Low magnification sample demonstrating 
endophytic growth pattern with subretinal fluid (hematoxylin and eosin).
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intraocular RB) [36]. On the other hand, Palazzi found that neovascular glaucoma 
was more likely to be associated with the exophytic tumor which may be due to the 
long-standing retinal detachment leading to ischemia. However, in that study, only 
the exophytic and endophytic growth patterns were studied without the mixed 
growth pattern [37].
3.6 Histopathology of retinoblastoma in enucleated globes following treatment
The well-differentiated part of the RB is relatively radioresistant and chemore-
sistant; therefore, photoreceptor differentiation is more common in the enucleated 
eyes after radiotherapy or chemotherapy [11].
The histopathological examination of the enucleated eyes with RB after che-
moreduction therapy may show Type 1, cottage cheese; Type 2, fish flesh; Type 
3, combination of types 1 and 2; and Type 4, complete regression or presumably 
viable histologically intact tumor cells [3, 41, 42]. Type 2 regression pattern may 
have the same histological features as a retinocytoma and result in a retinocytoma-
like clinical appearance, which may be because well-differentiated tumors are 
relatively resistant to chemotherapy and therefore the cells are not cycling [42]. 
Similar regression patterns are also seen in tumors treated by intra-arterial chemo-
therapy (IAC) [43].
4. American Joint Committee on Cancer (AJCC) classification
The American Joint Committee on Cancer and the International Union Against 
Cancer (AJCC/UICC) created a TNM staging scheme system for RB [26, 44–46]. It 
has multiple updated editions where the 8th edition is the latest updated one [45]. It 
is considered one of the extraocular classification systems besides the International 
Retinoblastoma Staging System (IRSS) [47]. Unlike other staging systems, TNM 
and IRSS were developed by multiple specialists and medical centers worldwide 
[48, 49]. The TNM8 system is subclassified into clinical, pathological, and heredi-
tary classifications which stand for cTNM, pTNM, and H, respectively [45]. 
Furthermore, pathological staging necessitates enucleation of the eye to classify 
primary tumor plus examining local extension or distant metastasis by biopsies or 
total resection if present. The pTNM categories are divided to pT, the histological 
staging of the primary tumor after biopsy or enucleation, pN stands for microscopic 
examination of lymph node biopsy, and clinical plus microscopic examination 
of distant metastatic lesions implies as M [45, 49]. However, on initial evaluation 
application of clinical or cTNM, subclassification is wildly used by ophthalmologist 
which subclassify the tumor burden to intraretinal, intraocular, advanced intraocu-
lar, or extraocular [47]. The clinical “cTNM” and hereditary “H” classification are 
beyond the scope of this chapter. Further details of pTNM classification and staging 
are demonstrated in Table 1 [45].
The updated pathological TNM8 version emphasized the importance to define 
focal, massive choroidal invasion and scleral invasion in compression to previ-
ously published TNM7 and TNM6 staging system in 2009 and 2002, respectively 
[45, 46, 49]. Furthermore, newly updated TNM8 staging system officially released 
formal staging group for prognosis. It is subdivided into four stages assigned for 
both clinical and pathological classifications as seen in Table 1 [45]. Guillermo 
reported poor disease-free survival in patients staged by the pTNM7 staging sys-
tem due to omission of scleral invasion. The major event of disease-free survival 
was extraocular relapse [49].
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Retinoblastoma is a subclassification composed of three aspects: pT, pN, and M. Pathological definition of 
primary tumor (pT): stands for histopathological staging of the primary tumor after biopsy or enucleation. 
Pathological definition of lymph node (pN): stands for microscopic examination of lymph node biopsy. Definition 
of distant metastasis (M): stands for grading distant metastatic lesions including both clinical and pathological 
definitions.
The abovementioned aspects of pTNM are categorized to 4 stages demonstrated in the last part of Table 1.
Table 1. 
Pathological TNM classification and staging by the AJCC/UICC for retinoblastoma.
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5. Conclusions
Histopathological examination of RB cases is highly valuable in diagnosing, 
staging, and predicting prognostic factors and risk of metastasis. Further attention 
should be given while evaluating the four submitted block sections to detect high-
risk features that indicate adjuvant chemotherapy administration that lowers meta-
static rate and improves the survival rate. The high-risk features include retrolaminar 
optic nerve invasion, choroidal invasion, anterior chamber involvement, extraocular 
or extra-scleral spread. Moreover, incidences of previously mentioned high-risk fea-
tures were studied in various articles. TNM staging created by AJCC/UICC provided 
pathological staging scheme for retinoblastoma. The recently released 8th edition 
in 2017 embedded choroidal and scleral invasion definition in tumor pathological 
staging section. In addition, formal prognostic stages were added.
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